Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg Formulations
Clinical trial NCT05103891 · UNKNOWN
Trial details
- NCT number
- NCT05103891
- Sponsor
- Pierre Fabre Medicament
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-03
- Primary completion
- 2021-11-29
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.